{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:51:38Z","timestamp":1791557498370,"version":"4.3.4"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00401-014-1371-2","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T05:53:31Z","timestamp":1418104411000},"page":"207-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":339,"title":["Tau aggregation and its interplay with amyloid-\u03b2"],"prefix":"10.1007","volume":"129","author":[{"given":"Rebecca M.","family":"Nisbet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Polanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars M.","family":"Ittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"issue":"28","key":"1371_CR1","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1523\/JNEUROSCI.4742-11.2012","volume":"32","author":"O Adolfsson","year":"2012","unstructured":"Adolfsson O, Pihlgren M, Toni N, Varisco Y, Buccarello AL, Antoniello K, Lohmann S, Piorkowska K, Gafner V, Atwal JK, Maloney J, Chen M, Gogineni A, Weimer RM, Mortensen DL, Friesenhahn M, Ho C, Paul R, Pfeifer A, Muhs A, Watts RJ (2012) An effector-reduced anti-beta-amyloid (Abeta) antibody with unique abeta binding properties promotes neuroprotection and glial engulfment of Abeta. J Neurosci Off J Soc Neurosci 32(28):9677\u20139689. doi: 10.1523\/JNEUROSCI.4742-11.2012","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1371_CR2","doi-asserted-by":"crossref","first-page":"980250","DOI":"10.1155\/2012\/980250","volume":"2012","author":"ZA Ahmad","year":"2012","unstructured":"Ahmad ZA, Yeap SK, Ali AM, Ho WY, Alitheen NB, Hamid M (2012) scFv antibody: principles and clinical application. Clin Dev Immunol 2012:980250. doi: 10.1155\/2012\/980250","journal-title":"Clin Dev Immunol"},{"issue":"34","key":"1371_CR3","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","volume":"27","author":"AA Asuni","year":"2007","unstructured":"Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM (2007) Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci Off J Soc Neurosci 27(34):9115\u20139129. doi: 10.1523\/JNEUROSCI.2361-07.2007","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"5","key":"1371_CR4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.cell.2014.07.001","volume":"158","author":"J Baleriola","year":"2014","unstructured":"Baleriola J, Walker CA, Jean YY, Crary JF, Troy CM, Nagy PL, Hengst U (2014) Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions. Cell 158(5):1159\u20131172. doi: 10.1016\/j.cell.2014.07.001","journal-title":"Cell"},{"issue":"9770","key":"1371_CR5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer\u2019s disease. Lancet 377(9770):1019\u20131031. doi: 10.1016\/S0140-6736(10)61349-9","journal-title":"Lancet"},{"issue":"8","key":"1371_CR6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6(8):916\u2013919. doi: 10.1038\/78682","journal-title":"Nat Med"},{"issue":"12","key":"1371_CR7","doi-asserted-by":"crossref","first-page":"e26860","DOI":"10.1371\/journal.pone.0026860","volume":"6","author":"M Bi","year":"2011","unstructured":"Bi M, Ittner A, Ke YD, G\u00f6tz J, Ittner LM (2011) Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice. PLoS One 6(12):e26860. doi: 10.1371\/journal.pone.0026860","journal-title":"PLoS One"},{"issue":"5","key":"1371_CR8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice. Neuron 45(5):675\u2013688. doi: 10.1016\/j.neuron.2005.01.040","journal-title":"Neuron"},{"issue":"4","key":"1371_CR9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71(4):505\u2013508. doi: 10.1001\/jamaneurol.2013.5847","journal-title":"JAMA Neurol"},{"issue":"1","key":"1371_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-010-0705-y","volume":"120","author":"D Boche","year":"2010","unstructured":"Boche D, Donald J, Love S, Harris S, Neal JW, Holmes C, Nicoll JA (2010) Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer\u2019s disease. Acta Neuropathol 120(1):13\u201320. doi: 10.1007\/s00401-010-0705-y","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1371_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2011-110977","volume":"28","author":"B Bohrmann","year":"2012","unstructured":"Bohrmann B, Baumann K, Benz J, Gerber F, Huber W, Knoflach F, Messer J, Oroszlan K, Rauchenberger R, Richter WF, Rothe C, Urban M, Bardroff M, Winter M, Nordstedt C, Loetscher H (2012) Gantenerumab: a novel human anti-Abeta antibody demonstrates sustained cerebral amyloid-beta binding and elicits cell-mediated removal of human amyloid-beta. J Alzheimer\u2019s Dis JAD 28(1):49\u201369. doi: 10.3233\/JAD-2011-110977","journal-title":"J Alzheimer\u2019s Dis JAD"},{"issue":"6","key":"1371_CR12","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2353\/ajpath.2007.070403","volume":"171","author":"T Bolmont","year":"2007","unstructured":"Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, Lewis J, Hutton M, Tolnay M, Jucker M (2007) Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol 171(6):2012\u20132020. doi: 10.2353\/ajpath.2007.070403","journal-title":"Am J Pathol"},{"issue":"4","key":"1371_CR13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","volume":"118","author":"A Boutajangout","year":"2011","unstructured":"Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM (2011) Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. J Neurochem 118(4):658\u2013667. doi: 10.1111\/j.1471-4159.2011.07337.x","journal-title":"J Neurochem"},{"issue":"49","key":"1371_CR14","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.1523\/JNEUROSCI.4363-10.2010","volume":"30","author":"A Boutajangout","year":"2010","unstructured":"Boutajangout A, Quartermain D, Sigurdsson EM (2010) Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. J Neurosci Off J Soc Neurosci 30(49):16559\u201316566. doi: 10.1523\/JNEUROSCI.4363-10.2010","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"3","key":"1371_CR15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E (1995) Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging 16(3):271\u2013278 discussion 278\u2013284","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1371_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1567205043332054","volume":"1","author":"R Brandt","year":"2004","unstructured":"Brandt R, Leschik J (2004) Functional interactions of tau and their relevance for Alzheimer\u2019s disease. Curr Alzheimer Res 1(4):255\u2013269","journal-title":"Curr Alzheimer Res"},{"issue":"12","key":"1371_CR17","doi-asserted-by":"crossref","first-page":"e29199","DOI":"10.1371\/journal.pone.0029199","volume":"6","author":"DC Butler","year":"2011","unstructured":"Butler DC, Messer A (2011) Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments. PLoS One 6(12):e29199. doi: 10.1371\/journal.pone.0029199","journal-title":"PLoS One"},{"issue":"12","key":"1371_CR18","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","volume":"34","author":"DL Castillo-Carranza","year":"2014","unstructured":"Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Lasagna-Reeves CA, Gerson JE, Singh G, Estes DM, Barrett AD, Dineley KT, Jackson GR, Kayed R (2014) Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci Off J Soc Neurosci 34(12):4260\u20134272. doi: 10.1523\/JNEUROSCI.3192-13.2014","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"4","key":"1371_CR19","doi-asserted-by":"crossref","first-page":"e18296","DOI":"10.1371\/journal.pone.0018296","volume":"6","author":"S Cattepoel","year":"2011","unstructured":"Cattepoel S, Hanenberg M, Kulic L, Nitsch RM (2011) Chronic intranasal treatment with an anti-Abeta(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. PLoS One 6(4):e18296. doi: 10.1371\/journal.pone.0018296","journal-title":"PLoS One"},{"key":"1371_CR20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2014.01.007","volume":"64","author":"MA Chabrier","year":"2014","unstructured":"Chabrier MA, Cheng D, Castello NA, Green KN, LaFerla FM (2014) Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer\u2019s disease. Neurobiol Dis 64:107\u2013117. doi: 10.1016\/j.nbd.2014.01.007","journal-title":"Neurobiol Dis"},{"issue":"39","key":"1371_CR21","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M111.229633","volume":"286","author":"X Chai","year":"2011","unstructured":"Chai X, Wu S, Murray TK, Kinley R, Cella CV, Sims H, Buckner N, Hanmer J, Davies P, O\u2019Neill MJ, Hutton ML, Citron M (2011) Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression. J Biol Chem 286(39):34457\u201334467. doi: 10.1074\/jbc.M111.229633","journal-title":"J Biol Chem"},{"issue":"2","key":"1371_CR22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cne.903250204","volume":"325","author":"ME Chicurel","year":"1992","unstructured":"Chicurel ME, Harris KM (1992) Three-dimensional analysis of the structure and composition of CA3 branched dendritic spines and their synaptic relationships with mossy fiber boutons in the rat hippocampus. J Comp Neurol 325(2):169\u2013182. doi: 10.1002\/cne.903250204","journal-title":"J Comp Neurol"},{"issue":"Pt 10","key":"1371_CR23","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awu213","volume":"137","author":"L Collin","year":"2014","unstructured":"Collin L, Bohrmann B, Gopfert U, Oroszlan-Szovik K, Ozmen L, Gruninger F (2014) Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer\u2019s disease. Brain J Neurol 137(Pt 10):2834\u20132846. doi: 10.1093\/brain\/awu213","journal-title":"Brain J Neurol"},{"issue":"49","key":"1371_CR24","doi-asserted-by":"crossref","first-page":"35452","DOI":"10.1074\/jbc.M113.491001","volume":"288","author":"EE Congdon","year":"2013","unstructured":"Congdon EE, Gu J, Sait HB, Sigurdsson EM (2013) Antibody uptake into neurons occurs primarily via clathrin-dependent Fcgamma receptor endocytosis and is a prerequisite for acute tau protein clearance. J Biol Chem 288(49):35452\u201335465. doi: 10.1074\/jbc.M113.491001","journal-title":"J Biol Chem"},{"issue":"4","key":"1371_CR25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R, Alzheimer\u2019s Disease Cooperative Study Steering C, Solanezumab Study G (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370(4):311\u2013321. doi: 10.1056\/NEJMoa1312889","journal-title":"N Engl J Med"},{"issue":"6","key":"1371_CR26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2013.03.002","volume":"36","author":"B DuBoff","year":"2013","unstructured":"DuBoff B, Feany M, G\u00f6tz J (2013) Why size matters\u2014balancing mitochondrial dynamics in Alzheimer\u2019s disease. Trends Neurosci 36(6):325\u2013335. doi: 10.1016\/j.tins.2013.03.002","journal-title":"Trends Neurosci"},{"issue":"19","key":"1371_CR27","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1073\/pnas.88.19.8362","volume":"88","author":"SA Frautschy","year":"1991","unstructured":"Frautschy SA, Baird A, Cole GM (1991) Effects of injected Alzheimer beta-amyloid cores in rat brain. Proc Natl Acad Sci USA 88(19):8362\u20138366","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1371_CR28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120(3):885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"issue":"6311","key":"1371_CR29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 349(6311):704\u2013706. doi: 10.1038\/349704a0","journal-title":"Nature"},{"issue":"5534","key":"1371_CR30","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J G\u00f6tz","year":"2001","unstructured":"G\u00f6tz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301\u00a0l tau transgenic mice induced by Abeta 42 fibrils. Science 293(5534):1491\u20131495. doi: 10.1126\/science.1062097","journal-title":"Science"},{"issue":"7","key":"1371_CR31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrn2420","volume":"9","author":"J G\u00f6tz","year":"2008","unstructured":"G\u00f6tz J, Ittner LM (2008) Animal models of Alzheimer\u2019s disease and frontotemporal dementia. Nat Rev Neurosci 9(7):532\u2013544. doi: 10.1038\/nrn2420","journal-title":"Nat Rev Neurosci"},{"key":"1371_CR32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fneur.2013.00072","volume":"4","author":"J G\u00f6tz","year":"2013","unstructured":"G\u00f6tz J, Xia D, Leinenga G, Chew YL, Nicholas H (2013) What Renders TAU Toxic. Front Neurol 4:72. doi: 10.3389\/fneur.2013.00072","journal-title":"Front Neurol"},{"issue":"2","key":"1371_CR33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.nbd.2009.09.004","volume":"37","author":"F Grueninger","year":"2010","unstructured":"Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L (2010) Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice. Neurobiol Dis 37(2):294\u2013306. doi: 10.1016\/j.nbd.2009.09.004","journal-title":"Neurobiol Dis"},{"issue":"13","key":"1371_CR34","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83(13):4913\u20134917","journal-title":"Proc Natl Acad Sci USA"},{"issue":"46","key":"1371_CR35","doi-asserted-by":"crossref","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","volume":"288","author":"J Gu","year":"2013","unstructured":"Gu J, Congdon EE, Sigurdsson EM (2013) Two novel Tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce Tau protein pathology. J Biol Chem 288(46):33081\u201333095. doi: 10.1074\/jbc.M113.494922","journal-title":"J Biol Chem"},{"issue":"17","key":"1371_CR36","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","volume":"286","author":"JL Guo","year":"2011","unstructured":"Guo JL, Lee VM (2011) Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286(17):15317\u201315331. doi: 10.1074\/jbc.M110.209296","journal-title":"J Biol Chem"},{"issue":"1","key":"1371_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neurobiolaging.2005.10.018","volume":"28","author":"KH Gylys","year":"2007","unstructured":"Gylys KH, Fein JA, Yang F, Miller CA, Cole GM (2007) Increased cholesterol in Abeta-positive nerve terminals from Alzheimer\u2019s disease cortex. Neurobiol Aging 28(1):8\u201317. doi: 10.1016\/j.neurobiolaging.2005.10.018","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1371_CR38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2051-5960-1-82","volume":"1","author":"NA Hoffmann","year":"2013","unstructured":"Hoffmann NA, Dorostkar MM, Blumenstock S, Goedert M, Herms J (2013) Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice. Acta Neuropathol Commun 1(1):82. doi: 10.1186\/2051-5960-1-82","journal-title":"Acta Neuropathol Commun"},{"issue":"14","key":"1371_CR39","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1073\/pnas.90.14.6444","volume":"90","author":"P Holliger","year":"1993","unstructured":"Holliger P, Prospero T, Winter G (1993) \u201cDiabodies\u201d: small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA 90(14):6444\u20136448","journal-title":"Proc Natl Acad Sci USA"},{"issue":"41","key":"1371_CR40","doi-asserted-by":"crossref","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC, Belaygorod L, Cairns NJ, Holtzman DM, Diamond MI (2014) Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci USA 111(41):E4376\u2013E4385. doi: 10.1073\/pnas.1411649111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1371_CR41","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68(6):1067\u20131081. doi: 10.1016\/j.neuron.2010.11.030","journal-title":"Neuron"},{"issue":"7","key":"1371_CR42","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2004.09.016","volume":"26","author":"NC Inestrosa","year":"2005","unstructured":"Inestrosa NC, Reyes AE, Chacon MA, Cerpa W, Villalon A, Montiel J, Merabachvili G, Aldunate R, Bozinovic F, Aboitiz F (2005) Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu. Neurobiol Aging 26(7):1023\u20131028. doi: 10.1016\/j.neurobiolaging.2004.09.016","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1371_CR43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, G\u00f6tz J (2011) Amyloid-beta and tau\u2013a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci 12(2):65\u201372. doi: 10.1038\/nrn2967","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"1371_CR44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, G\u00f6tz J (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell 142(3):387\u2013397. doi: 10.1016\/j.cell.2010.06.036","journal-title":"Cell"},{"issue":"35","key":"1371_CR45","doi-asserted-by":"crossref","first-page":"11621","DOI":"10.1523\/JNEUROSCI.1405-14.2014","volume":"34","author":"H Jacobsen","year":"2014","unstructured":"Jacobsen H, Ozmen L, Caruso A, Narquizian R, Hilpert H, Jacobsen B, Terwel D, Tanghe A, Bohrmann B (2014) Combined treatment with a BACE inhibitor and Anti-Abeta antibody gantenerumab enhances amyloid reduction in APPLondon Mice. J Neurosci Off J Soc Neurosci 34(35):11621\u201311630. doi: 10.1523\/JNEUROSCI.1405-14.2014","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"15","key":"1371_CR46","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5543-03.2004","volume":"24","author":"T Kawarabayashi","year":"2004","unstructured":"Kawarabayashi T, Shoji M, Younkin LH, Wen-Lang L, Dickson DW, Murakami T, Matsubara E, Abe K, Ashe KH, Younkin SG (2004) Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer\u2019s disease. J Neurosci Off J Soc Neurosci 24(15):3801\u20133809. doi: 10.1523\/JNEUROSCI.5543-03.2004","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"2","key":"1371_CR47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nn.3606","volume":"17","author":"UA Khan","year":"2014","unstructured":"Khan UA, Liu L, Provenzano FA, Berman DE, Profaci CP, Sloan R, Mayeux R, Duff KE, Small SA (2014) Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease. Nat Neurosci 17(2):304\u2013311. doi: 10.1038\/nn.3606","journal-title":"Nat Neurosci"},{"issue":"1","key":"1371_CR48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nbd.2005.10.002","volume":"22","author":"L Kulic","year":"2006","unstructured":"Kulic L, Kurosinski P, Chen F, Tracy J, Mohajeri MH, Li H, Nitsch RM, G\u00f6tz J (2006) Active immunization trial in Abeta42-injected P301L tau transgenic mice. Neurobiol Dis 22(1):50\u201356. doi: 10.1016\/j.nbd.2005.10.002","journal-title":"Neurobiol Dis"},{"issue":"7233","key":"1371_CR49","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Lauren","year":"2009","unstructured":"Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457(7233):1128\u20131132. doi: 10.1038\/nature07761","journal-title":"Nature"},{"issue":"Pt 21","key":"1371_CR50","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1242\/jcs.111.21.3167","volume":"111","author":"G Lee","year":"1998","unstructured":"Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G (1998) Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 111(Pt 21):3167\u20133177","journal-title":"J Cell Sci"},{"issue":"9","key":"1371_CR51","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","volume":"24","author":"G Lee","year":"2004","unstructured":"Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, Do LH, Andreadis A, Van Hoesen G, Ksiezak-Reding H (2004) Phosphorylation of tau by fyn: implications for Alzheimer\u2019s disease. J Neurosci Off J Soc Neurosci 24(9):2304\u20132312. doi: 10.1523\/JNEUROSCI.4162-03.2004","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"7082","key":"1371_CR52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440(7082):352\u2013357. doi: 10.1038\/nature04533","journal-title":"Nature"},{"issue":"46","key":"1371_CR53","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.1523\/JNEUROSCI.2795-06.2006","volume":"26","author":"Y Levites","year":"2006","unstructured":"Levites Y, Jansen K, Smithson LA, Dakin R, Holloway VM, Das P, Golde TE (2006) Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. J Neurosci Off J Soc Neurosci 26(46):11923\u201311928. doi: 10.1523\/JNEUROSCI.2795-06.2006","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"14","key":"1371_CR54","first-page":"2576","volume":"20","author":"Y Levites","year":"2006","unstructured":"Levites Y, Smithson LA, Price RW, Dakin RS, Yuan B, Sierks MR, Kim J, McGowan E, Reed DK, Rosenberry TL, Das P, Golde TE (2006) Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer\u2019s disease mouse models. FASEB J Off Publ Fed Am Soc Exp Biol 20(14):2576\u20132578. doi: 10.1096\/fj.06-6463fje","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"5534","key":"1371_CR55","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293(5534):1487\u20131491. doi: 10.1126\/science.1058189","journal-title":"Science"},{"issue":"6","key":"1371_CR56","doi-asserted-by":"crossref","first-page":"e66084","DOI":"10.1371\/journal.pone.0066084","volume":"8","author":"KJ Lim","year":"2013","unstructured":"Lim KJ, Sung BH, Shin JR, Lee YW, da Kim J, Yang KS, Kim SC (2013) A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells. PLoS One 8(6):e66084. doi: 10.1371\/journal.pone.0066084","journal-title":"PLoS One"},{"issue":"12","key":"1371_CR57","doi-asserted-by":"crossref","first-page":"e84849","DOI":"10.1371\/journal.pone.0084849","volume":"8","author":"C Liu","year":"2013","unstructured":"Liu C, G\u00f6tz J (2013) Profiling murine tau with 0\u00a0N, 1\u00a0N and 2\u00a0N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1\u00a0N isoform being enriched in the nucleus. PLoS One 8(12):e84849. doi: 10.1371\/journal.pone.0084849","journal-title":"PLoS One"},{"issue":"22","key":"1371_CR58","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1021\/bi049933o","volume":"43","author":"R Liu","year":"2004","unstructured":"Liu R, Yuan B, Emadi S, Zameer A, Schulz P, McAllister C, Lyubchenko Y, Goud G, Sierks MR (2004) Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity. Biochemistry 43(22):6959\u20136967. doi: 10.1021\/bi049933o","journal-title":"Biochemistry"},{"issue":"1","key":"1371_CR59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuron.2013.02.003","volume":"78","author":"G Mairet-Coello","year":"2013","unstructured":"Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A, Polleux F (2013) The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Abeta oligomers through Tau phosphorylation. Neuron 78(1):94\u2013108. doi: 10.1016\/j.neuron.2013.02.003","journal-title":"Neuron"},{"issue":"4","key":"1371_CR60","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnen\/60.4.357","volume":"60","author":"E Masliah","year":"2001","unstructured":"Masliah E, Sisk A, Mallory M, Games D (2001) Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. J Neuropathol Exp Neurol 60(4):357\u2013368","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6012","key":"1371_CR61","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330(6012):1774. doi: 10.1126\/science.1197623","journal-title":"Science"},{"issue":"6","key":"1371_CR62","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46(6):860\u2013866","journal-title":"Ann Neurol"},{"issue":"24","key":"1371_CR63","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","volume":"267","author":"H Mori","year":"1992","unstructured":"Mori H, Takio K, Ogawara M, Selkoe DJ (1992) Mass spectrometry of purified amyloid beta protein in Alzheimer\u2019s disease. J Biol Chem 267(24):17082\u201317086","journal-title":"J Biol Chem"},{"issue":"23","key":"1371_CR64","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1073\/pnas.0703137104","volume":"104","author":"A Muhs","year":"2007","unstructured":"Muhs A, Hickman DT, Pihlgren M, Chuard N, Giriens V, Meerschman C, van der Auwera I, van Leuven F, Sugawara M, Weingertner MC, Bechinger B, Greferath R, Kolonko N, Nagel-Steger L, Riesner D, Brady RO, Pfeifer A, Nicolau C (2007) Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice. Proc Natl Acad Sci USA 104(23):9810\u20139815. doi: 10.1073\/pnas.0703137104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1371_CR65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1(5):345\u2013347. doi: 10.1038\/ng0892-345","journal-title":"Nat Genet"},{"issue":"5028","key":"1371_CR66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1925564","volume":"254","author":"J Murrell","year":"1991","unstructured":"Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer\u2019s disease. Science 254(5028):97\u201399","journal-title":"Science"},{"issue":"12","key":"1371_CR67","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","volume":"283","author":"J Naslund","year":"2000","unstructured":"Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA J Am Med Assoc 283(12):1571\u20131577","journal-title":"JAMA J Am Med Assoc"},{"issue":"4","key":"1371_CR68","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","volume":"9","author":"JA Nicoll","year":"2003","unstructured":"Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9(4):448\u2013452. doi: 10.1038\/nm840","journal-title":"Nat Med"},{"issue":"9","key":"1371_CR69","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"C Nilsberth","year":"2001","unstructured":"Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Naslund J, Lannfelt L (2001) The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation. Nat Neurosci 4(9):887\u2013893. doi: 10.1038\/nn0901-887","journal-title":"Nat Neurosci"},{"issue":"10","key":"1371_CR70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/protein\/gzt025","volume":"26","author":"RM Nisbet","year":"2013","unstructured":"Nisbet RM, Nigro J, Breheney K, Caine J, Hattarki MK, Nuttall SD (2013) Central amyloid-beta-specific single chain variable fragment ameliorates Abeta aggregation and neurotoxicity. Protein Eng Des Sel PEDS 26(10):571\u2013580. doi: 10.1093\/protein\/gzt025","journal-title":"Protein Eng Des Sel PEDS"},{"issue":"3","key":"1371_CR71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43(3):321\u2013332. doi: 10.1016\/j.neuron.2004.07.003","journal-title":"Neuron"},{"issue":"3","key":"1371_CR72","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39(3):409\u2013421","journal-title":"Neuron"},{"issue":"51","key":"1371_CR73","doi-asserted-by":"crossref","first-page":"39413","DOI":"10.1074\/jbc.M608485200","volume":"281","author":"S Oddo","year":"2006","unstructured":"Oddo S, Vasilevko V, Caccamo A, Kitazawa M, Cribbs DH, LaFerla FM (2006) Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 281(51):39413\u201339423. doi: 10.1074\/jbc.M608485200","journal-title":"J Biol Chem"},{"issue":"1","key":"1371_CR74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","volume":"61","author":"JM Orgogozo","year":"2003","unstructured":"Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, Jouanny P, Dubois B, Eisner L, Flitman S, Michel BF, Boada M, Frank A, Hock C (2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61(1):46\u201354","journal-title":"Neurology"},{"key":"1371_CR75","author":"K Paholikova","year":"2014","unstructured":"Paholikova K, Salingova B, Opattova A, Skrabana R, Majerova P, Zilka N, Kovacech B, Zilkova M, Barath P, Novak M (2014) N-terminal truncation of microtubule associated protein tau dysregulates its cellular localization. J Alzheimer\u2019s Dis JAD. doi: 10.3233\/JAD-140996","journal-title":"J Alzheimer\u2019s Dis JAD"},{"issue":"2","key":"1371_CR76","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","volume":"82","author":"MP Parsons","year":"2014","unstructured":"Parsons MP, Raymond LA (2014) Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 82(2):279\u2013293. doi: 10.1016\/j.neuron.2014.03.030","journal-title":"Neuron"},{"issue":"5597","key":"1371_CR77","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.1078259","volume":"298","author":"M Pfeifer","year":"2002","unstructured":"Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M (2002) Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298(5597):1379. doi: 10.1126\/science.1078259","journal-title":"Science"},{"issue":"3","key":"1371_CR78","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","volume":"25","author":"MM Racke","year":"2005","unstructured":"Racke MM, Boone LI, Hepburn DL, Parsadainian M, Bryan MT, Ness DK, Piroozi KS, Jordan WH, Brown DD, Hoffman WP, Holtzman DM, Bales KR, Gitter BD, May PC, Paul SM, DeMattos RB (2005) Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta. J Neurosci Off J Soc Neurosci 25(3):629\u2013636. doi: 10.1523\/JNEUROSCI.4337-04.2005","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"4","key":"1371_CR79","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jnc.12305","volume":"126","author":"S Rasool","year":"2013","unstructured":"Rasool S, Martinez-Coria H, Wu JW, LaFerla F, Glabe CG (2013) Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Abeta deposition and tau pathology in 3xTg-AD mice. J Neurochem 126(4):473\u2013482. doi: 10.1111\/jnc.12305","journal-title":"J Neurochem"},{"issue":"47","key":"1371_CR80","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1073\/pnas.0905529106","volume":"106","author":"V Rhein","year":"2009","unstructured":"Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Drose S, Brandt U, Savaskan E, Czech C, G\u00f6tz J, Eckert A (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice. Proc Natl Acad Sci USA 106(47):20057\u201320062. doi: 10.1073\/pnas.0905529106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5825","key":"1371_CR81","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model. Science 316(5825):750\u2013754. doi: 10.1126\/science.1141736","journal-title":"Science"},{"issue":"10","key":"1371_CR82","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/archneur.63.10.1459","volume":"63","author":"H Rosenmann","year":"2006","unstructured":"Rosenmann H, Grigoriadis N, Karussis D, Boimel M, Touloumi O, Ovadia H, Abramsky O (2006) Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch Neurol 63(10):1459\u20131467. doi: 10.1001\/archneur.63.10.1459","journal-title":"Arch Neurol"},{"issue":"4","key":"1371_CR83","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR, Bapineuzumab, Clinical Trial I (2014) Two phase 3 trials of Bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370(4):322\u2013333. doi: 10.1056\/NEJMoa1304839","journal-title":"N Engl J Med"},{"issue":"42","key":"1371_CR84","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, Devidze N, Ho K, Yu GQ, Palop JJ, Mucke L (2012) Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci USA 109(42):E2895\u2013E2903. doi: 10.1073\/pnas.1121081109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5733","key":"1371_CR85","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309(5733):476\u2013481. doi: 10.1126\/science.1113694","journal-title":"Science"},{"issue":"18","key":"1371_CR86","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","volume":"68","author":"SW Scheff","year":"2007","unstructured":"Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68(18):1501\u20131508. doi: 10.1212\/01.wnl.0000260698.46517.8f","journal-title":"Neurology"},{"issue":"10","key":"1371_CR87","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging 27(10):1372\u20131384. doi: 10.1016\/j.neurobiolaging.2005.09.012","journal-title":"Neurobiol Aging"},{"issue":"6740","key":"1371_CR88","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400(6740):173\u2013177. doi: 10.1038\/22124","journal-title":"Nature"},{"issue":"2","key":"1371_CR89","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000112834","volume":"5","author":"P Seubert","year":"2008","unstructured":"Seubert P, Barbour R, Khan K, Motter R, Tang P, Kholodenko D, Kling K, Schenk D, Johnson-Wood K, Schroeter S, Gill D, Jacobsen JS, Pangalos M, Basi G, Games D (2008) Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mouse. Neurodegener Dis 5(2):65\u201371. doi: 10.1159\/000112834","journal-title":"Neurodegener Dis"},{"issue":"11","key":"1371_CR90","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci Off J Soc Neurosci 27(11):2866\u20132875. doi: 10.1523\/JNEUROSCI.4970-06.2007","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"6","key":"1371_CR91","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0197-4580(97)00154-1","volume":"18","author":"EM Sigurdsson","year":"1997","unstructured":"Sigurdsson EM, Lee JM, Dong XW, Hejna MJ, Lorens SA (1997) Bilateral injections of amyloid-beta 25\u201335 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects. Neurobiol Aging 18(6):591\u2013608","journal-title":"Neurobiol Aging"},{"issue":"8","key":"1371_CR92","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","volume":"8","author":"EM Snyder","year":"2005","unstructured":"Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8(8):1051\u20131058. doi: 10.1038\/nn1503","journal-title":"Nat Neurosci"},{"issue":"1","key":"1371_CR93","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1073\/pnas.93.1.452","volume":"93","author":"B Solomon","year":"1996","unstructured":"Solomon B, Koppel R, Hanan E, Katzav T (1996) Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Proc Natl Acad Sci USA 93(1):452\u2013455","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1371_CR94","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T","volume":"10","author":"KE Sorra","year":"2000","unstructured":"Sorra KE, Harris KM (2000) Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines. Hippocampus 10(5):501\u2013511. doi: 10.1002\/1098-1063(2000)10:5<501:AID-HIPO1>3.0.CO;2-T","journal-title":"Hippocampus"},{"issue":"43","key":"1371_CR95","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell AL, Ko J, Patterson PH (2009) Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease. J Neurosci Off J Soc Neurosci 29(43):13589\u201313602. doi: 10.1523\/JNEUROSCI.4286-09.2009","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"12","key":"1371_CR96","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1091\/mbc.E07-04-0327","volume":"18","author":"ML Steinhilb","year":"2007","unstructured":"Steinhilb ML, Dias-Santagata D, Fulga TA, Felch DL, Feany MB (2007) Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol Biol Cell 18(12):5060\u20135068. doi: 10.1091\/mbc.E07-04-0327","journal-title":"Mol Biol Cell"},{"issue":"8","key":"1371_CR97","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.febslet.2009.03.017","volume":"583","author":"CC Swanwick","year":"2009","unstructured":"Swanwick CC, Shapiro ME, Yi Z, Chang K, Wenthold RJ (2009) NMDA receptors interact with flotillin-1 and -2, lipid raft-associated proteins. FEBS Lett 583(8):1226\u20131230. doi: 10.1016\/j.febslet.2009.03.017","journal-title":"FEBS Lett"},{"issue":"8","key":"1371_CR98","doi-asserted-by":"crossref","first-page":"e72301","DOI":"10.1371\/journal.pone.0072301","volume":"8","author":"C Theunis","year":"2013","unstructured":"Theunis C, Crespo-Biel N, Gafner V, Pihlgren M, Lopez-Deber MP, Reis P, Hickman DT, Adolfsson O, Chuard N, Ndao DM, Borghgraef P, Devijver H, Van Leuven F, Pfeifer A, Muhs A (2013) Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy. PLoS One 8(8):e72301. doi: 10.1371\/journal.pone.0072301","journal-title":"PLoS One"},{"issue":"4","key":"1371_CR99","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/156720512800492503","volume":"9","author":"L Troquier","year":"2012","unstructured":"Troquier L, Caillierez R, Burnouf S, Fernandez-Gomez FJ, Grosjean ME, Zommer N, Sergeant N, Schraen-Maschke S, Blum D, Buee L (2012) Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res 9(4):397\u2013405","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"1371_CR100","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM (2012) Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15(9):1227\u20131235. doi: 10.1038\/nn.3178","journal-title":"Nat Neurosci"},{"issue":"9","key":"1371_CR101","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.neurobiolaging.2009.10.008","volume":"32","author":"T Groen van","year":"2011","unstructured":"van Groen T, Kadish I, Popovic N, Popovic M, Caballero-Bleda M, Bano-Otalora B, Vivanco P, Rol MA, Madrid JA (2011) Age-related brain pathology in Octodon degu: blood vessel, white matter and Alzheimer-like pathology. Neurobiol Aging 32(9):1651\u20131661. doi: 10.1016\/j.neurobiolaging.2009.10.008","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1371_CR102","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1523\/JNEUROSCI.5077-10.2011","volume":"31","author":"A Wang","year":"2011","unstructured":"Wang A, Das P, Switzer RC 3rd, Golde TE, Jankowsky JL (2011) Robust amyloid clearance in a mouse model of Alzheimer\u2019s disease provides novel insights into the mechanism of amyloid-beta immunotherapy. J Neurosci Off J Soc Neurosci 31(11):4124\u20134136. doi: 10.1523\/JNEUROSCI.5077-10.2011","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"8","key":"1371_CR103","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","volume":"275","author":"HY Wang","year":"2000","unstructured":"Wang HY, Lee DH, D\u2019Andrea MR, Peterson PA, Shank RP, Reitz AB (2000) beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer\u2019s disease pathology. J Biol Chem 275(8):5626\u20135632","journal-title":"J Biol Chem"},{"issue":"3","key":"1371_CR104","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1046\/j.1471-4159.2000.0751155.x","volume":"75","author":"HY Wang","year":"2000","unstructured":"Wang HY, Lee DH, Davis CB, Shank RP (2000) Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 75(3):1155\u20131161","journal-title":"J Neurochem"},{"issue":"25","key":"1371_CR105","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1523\/JNEUROSCI.1339-09.2009","volume":"29","author":"DM Wilcock","year":"2009","unstructured":"Wilcock DM, Gharkholonarehe N, Van Nostrand WE, Davis J, Vitek MP, Colton CA (2009) Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer\u2019s disease. J Neurosci Off J Soc Neurosci 29(25):7957\u20137965. doi: 10.1523\/JNEUROSCI.1339-09.2009","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"27","key":"1371_CR106","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1523\/JNEUROSCI.1090-04.2004","volume":"24","author":"DM Wilcock","year":"2004","unstructured":"Wilcock DM, Rojiani A, Rosenthal A, Levkowitz G, Subbarao S, Alamed J, Wilson D, Wilson N, Freeman MJ, Gordon MN, Morgan D (2004) Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci Off J Soc Neurosci 24(27):6144\u20136151. doi: 10.1523\/JNEUROSCI.1090-04.2004","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"3","key":"1371_CR107","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H, Cirrito JR, Patel TK, Hochgrafe K, Mandelkow EM, Holtzman DM (2014) Neuronal activity regulates extracellular tau in vivo. J Exp Med 211(3):387\u2013393. doi: 10.1084\/jem.20131685","journal-title":"J Exp Med"},{"issue":"2","key":"1371_CR108","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra K, Kfoury N, Jiang H, Mahan TE, Ma S, Maloney SE, Wozniak DF, Diamond MI, Holtzman DM (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80(2):402\u2013414. doi: 10.1016\/j.neuron.2013.07.046","journal-title":"Neuron"},{"key":"1371_CR109","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1038\/srep05705","volume":"4","author":"A Yasue","year":"2014","unstructured":"Yasue A, Mitsui SN, Watanabe T, Sakuma T, Oyadomari S, Yamamoto T, Noji S, Mito T, Tanaka E (2014) Highly efficient targeted mutagenesis in one-cell mouse embryos mediated by the TALEN and CRISPR\/Cas systems. Sci Rep 4:5705. doi: 10.1038\/srep05705","journal-title":"Sci Rep"},{"issue":"6","key":"1371_CR110","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/hmg\/ddr576","volume":"21","author":"W Yu","year":"2012","unstructured":"Yu W, Polepalli J, Wagh D, Rajadas J, Malenka R, Lu B (2012) A critical role for the PAR-1\/MARK-tau axis in mediating the toxic effects of Abeta on synapses and dendritic spines. Hum Mol Genet 21(6):1384\u20131390. doi: 10.1093\/hmg\/ddr576","journal-title":"Hum Mol Genet"},{"issue":"84","key":"1371_CR111","first-page":"84ra44","volume":"3","author":"YJ Yu","year":"2011","unstructured":"Yu YJ, Zhang Y, Kenrick M, Hoyte K, Luk W, Lu Y, Atwal J, Elliott JM, Prabhu S, Watts RJ, Dennis MS (2011) Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med 3(84):84ra44. doi: 10.1126\/scitranslmed.3002230","journal-title":"Sci Transl Med"},{"issue":"36","key":"1371_CR112","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","volume":"30","author":"H Zempel","year":"2010","unstructured":"Zempel H, Thies E, Mandelkow E, Mandelkow EM (2010) Abeta oligomers cause localized Ca(2\u00a0+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci Off J Soc Neurosci 30(36):11938\u201311950. doi: 10.1523\/JNEUROSCI.2357-10.2010","journal-title":"J Neurosci Off J Soc Neurosci"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-014-1371-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-014-1371-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-014-1371-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T02:49:17Z","timestamp":1650768557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-014-1371-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,10]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["1371"],"URL":"https:\/\/doi.org\/10.1007\/s00401-014-1371-2","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,10]]}}}